Michael Somers
Overview
Explore the profile of Michael Somers including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
218
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Campbell B, Kacin A, Morey J, Risley C, Ashoor I, Ferguson M, et al.
Laryngoscope
. 2025 Jan;
PMID: 39887368
Objective: Posttransplant lymphoproliferative disorder (PTLD) is a complication of pediatric solid organ transplantation. Benign adenotonsillar lymphoid hyperplasia confounds the ability to diagnose PTLD. Our aim was to identify factors that...
2.
Arras W, Breugelmans T, Oosterlinck B, De Man J, Malhotra-Kumar S, Abrams S, et al.
J Crohns Colitis
. 2024 Sep;
PMID: 39330996
Background And Aims: Mucosal healing is considered as a key therapeutic endpoint in inflammatory bowel diseases (IBD) and comprises endoscopic improvement of inflammation without taking barrier healing into account. Mucins...
3.
Raina R, Jothi S, Haffner D, Somers M, Filler G, Vasistha P, et al.
Kidney Int
. 2023 Dec;
105(3):450-463.
PMID: 38142038
Focal segmental glomerular sclerosis (FSGS) is 1 of the primary causes of nephrotic syndrome in both pediatric and adult patients, which can lead to end-stage kidney disease. Recurrence of FSGS...
4.
Moudgil A, Sgambat K, Benoit E, Seifert M, Bharadwaj M, Jain A, et al.
Pediatr Transplant
. 2023 Oct;
28(1):e14628.
PMID: 37877312
Background: Mycophenolate Mofetil (MMF) is an effective immunosuppressant used in kidney transplant recipients to prevent acute rejection. Complications such as diarrhea, leukopenia, and infections may necessitate the reduction or discontinuation...
5.
Lemmens P, Louis E, van Moerkercke W, Pouillon L, Somers M, Peeters H, et al.
Clin Gastroenterol Hepatol
. 2023 Jul;
22(1):154-163.e3.
PMID: 37442318
Background & Aims: Several advanced therapies (biologic therapies and small molecules) have been approved for the treatment of moderate-to-severe ulcerative colitis. The registration trials for these agents typically excluded patients...
6.
Haddad E, Hayes L, Price D, Vallery C, Somers M, Borer J
Pediatr Nephrol
. 2023 Jul;
39(2):371-382.
PMID: 37410166
Individuals with bladder exstrophy-epispadias complex (EEC) need long-term integrated medical/surgical and psychosocial care. These individuals are at risk for medical and surgical complications and experience social and psychological obstacles related...
7.
Tummalapalli S, Struthers S, White D, Beckrich A, Brahmbhatt Y, Erickson K, et al.
J Am Soc Nephrol
. 2023 Jul;
34(8):1315-1328.
PMID: 37400103
The Merit-based Incentive Payment System (MIPS) is a mandatory pay-for-performance program through the Centers for Medicare & Medicaid Services (CMS) that aims to incentivize high-quality care, promote continuous improvement, facilitate...
8.
Erez D, Pizzo H, Rodig N, Richardson T, Somers M
Pediatr Nephrol
. 2023 Jul;
38(10):3503.
PMID: 37395803
No abstract available.
9.
Breugelmans T, Arras W, Oosterlinck B, Jauregui-Amezaga A, Somers M, Cuypers B, et al.
Cells
. 2023 May;
12(9).
PMID: 37174625
Overexpression of the transmembrane mucin MUC13, as seen in inflammatory bowel diseases (IBD), could potentially impact barrier function. This study aimed to explore how inflammation-induced MUC13 disrupts epithelial barrier integrity...
10.
Erez D, Pizzo H, Rodig N, Richardson T, Somers M
Pediatr Nephrol
. 2023 May;
38(10):3455-3464.
PMID: 37154962
Background: Induction agent used at the time of kidney transplant is often based upon center practice and recipient characteristics. We evaluated outcomes across induction therapies among children enrolled in the...